Mesenchymal Stem Cell Transplantation Inhibits Abnormal Activation of Akt/GSK3β Signaling Pathway in T Cells from Systemic Lupus Erythematosus Mice

被引:35
作者
Ji, Suyun [1 ]
Guo, Qing [1 ]
Han, Yanfang [1 ]
Tan, Guozhen [1 ]
Luo, Yijin [1 ]
Zeng, Fanqin [1 ]
机构
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Dermatol, Guangzhou 510120, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
Systemic lupus erythematosus; Bone marrow mesenchymal stem cell; Transplantation; Cell cycle; Akt; GSK3; beta; MARROW STROMAL CELLS; BONE-MARROW; MRL/LPR MICE; PROLIFERATION; SURVIVAL; PROTEIN; AUTOIMMUNITY; DISTINCT; DISEASE; MODEL;
D O I
10.1159/000178590
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by activation and proliferation of autoreactive T cells and B cells. We examined changes in cell cycle progression of T cells from MRL/lpr mice with or without allogenic bone marrow mesenchymal stem cells (BMMSCs) treatment and analyzed the expression of cell cycle associated proteins. In addition, the Akt/GSK3 beta protein kinase cascade was studied. We demonstrated that high-dose MSCs transplantation effectively ameliorated disease activity in MRL/lpr mice. BMMSCs treatment inhibited G1/S transition of the abnormal lupus T lymphocytes. Moreover, it increased the expression of p21(WAF1/CIP1) and p27(Kip1) and decreased the expression of CDK2. Furthermore, high-dose MSCs inhibited abnormal activation of the Akt/GSK3 beta signaling pathway of T cells from MRL/lpr mice. Our results suggest that high-dose BMMSCs transplantation successfully treated MRL/lpr lupus mice by inhibiting abnormal activation of Akt/GSK3 beta signaling pathway of T cells. Copyright (c) 2012 S. Karger AG, Basel
引用
收藏
页码:705 / 712
页数:8
相关论文
共 37 条
[1]   Mechanism of activation of protein kinase B by insulin and IGF-1 [J].
Alessi, DR ;
Andjelkovic, M ;
Caudwell, B ;
Cron, P ;
Morrice, N ;
Cohen, P ;
Hemmings, BA .
EMBO JOURNAL, 1996, 15 (23) :6541-6551
[2]   The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development [J].
Balomenos, D ;
Martín-Caballero, J ;
García, MI ;
Prieto, I ;
Flores, JM ;
Serrano, M ;
Martínez, C .
NATURE MEDICINE, 2000, 6 (02) :171-176
[3]   PI3Kγ inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus [J].
Barber, DF ;
Bartolomé, A ;
Hernandez, C ;
Flores, JM ;
Redondo, C ;
Fernandez-Arias, C ;
Camps, M ;
Ruckle, T ;
Schwarz, MK ;
Rodríguez, S ;
Martinez-A, C ;
Balomenos, D ;
Rommel, C ;
Carrera, AC .
NATURE MEDICINE, 2005, 11 (09) :933-935
[4]   Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J].
Bartholomew, A ;
Sturgeon, C ;
Siatskas, M ;
Ferrer, K ;
McIntosh, K ;
Patil, S ;
Hardy, W ;
Devine, S ;
Ucker, D ;
Deans, R ;
Moseley, A ;
Hoffman, R .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :42-48
[5]  
Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO
[6]  
2-C
[7]   Human mesenchymal stem cells modulate B-cell functions [J].
Corcione, A ;
Benvenuto, F ;
Ferretti, E ;
Giunti, D ;
Cappiello, V ;
Cazzanti, F ;
Risso, M ;
Gualandi, F ;
Mancardi, GL ;
Pistoia, V ;
Uccelli, A .
BLOOD, 2006, 107 (01) :367-372
[8]   Impaired Fas response and autoimmunity in Pten+/- mice [J].
Di Cristofano, A ;
Kotsi, P ;
Peng, YF ;
Cordon-Cardo, C ;
Elkon, KB ;
Pandolfi, PP .
SCIENCE, 1999, 285 (5436) :2122-2125
[9]   Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli [J].
Di Nicola, M ;
Carlo-Stella, C ;
Magni, M ;
Milanesi, M ;
Longoni, PD ;
Matteucci, P ;
Grisanti, S ;
Gianni, AM .
BLOOD, 2002, 99 (10) :3838-3843
[10]   THE FAS PROTEIN IS EXPRESSED AT HIGH-LEVELS ON CD4+CD8+ THYMOCYTES AND ACTIVATED MATURE LYMPHOCYTES IN NORMAL MICE BUT NOT IN THE LUPUS-PRONE STRAIN, MRL LPR/LPR [J].
DRAPPA, J ;
BROT, N ;
ELKON, KB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (21) :10340-10344